Cindy Tahl, General Counsel and Secretary at FATE THERAPEUTICS INC (FATE), sold 59,211 shares at $90.30 ($5.1M) on 2021-07-01, disclosed to the SEC on 2021-07-02.
Open-market sale of $5.1M FATE by General Counsel and Secretary. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $84.56 | 50,000 | $4.2M | 83.4% |
| 2 | $84.83 | 100 | $8K | 0.2% |
| 3 | $86.56 | 200 | $17K | 0.3% |
| 4 | $87.90 | 1,145 | $101K | 2.0% |
| 5 | $87.90 | 1,145 | $101K | 2.0% |
| 6 | $88.93 | 400 |
| $36K |
| 0.7% |
| 7 | $90.30 | 707 | $64K | 1.3% |
| 8 | $90.30 | 707 | $64K | 1.3% |
| 9 | $91.06 | 225 | $20K | 0.4% |
| 10 | $92.26 | 432 | $40K | 0.8% |
| 11 | $93.31 | 400 | $37K | 0.7% |
| 12 | $94.63 | 1,825 | $173K | 3.4% |
| 13 | $94.63 | 1,825 | $173K | 3.4% |
| 14 | $95.30 | 100 | $10K | 0.2% |
| Total | $85.64 avg | 59,211 | $5.1M | 100% |
| Filing → |
| FATE | SELL | 2026-01-12 | $11K | — | Filing → |
| FATE | SELL | 2025-08-05 | $10K | — | Filing → |
| FATE | SELL | 2025-01-13 | $9K | — | Filing → |